The therapeutic potential of small molecule TACE inhibitors
- 1 April 1999
- journal article
- Published by Taylor & Francis in Expert Opinion on Investigational Drugs
- Vol. 8 (4) , 383-392
- https://doi.org/10.1517/13543784.8.4.383
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- An Essential Role for Ectodomain Shedding in Mammalian DevelopmentScience, 1998
- TNF‐α converting enzyme (TACE) is inhibited by TIMP‐3FEBS Letters, 1998
- Design and Synthesis of Cyclic Inhibitors of Matrix Metalloproteinases and TNF-α ProductionJournal of Medicinal Chemistry, 1998
- Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-αNature, 1997
- A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cellsNature, 1997
- Tumor Necrosis Factor: Function, Release and ClearanceCritical Reviews in Immunology, 1996
- Novel indolactam-based inhibitors of matrix metalloproteinasesBioorganic & Medicinal Chemistry Letters, 1995
- Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processingNature, 1994
- Abnormal Development of Peripheral Lymphoid Organs in Mice Deficient in LymphotoxinScience, 1994
- TUMOR NECROSIS FACTOR: A Pleiotropic Cytokine and Therapuetic TargetAnnual Review of Medicine, 1994